Kil Hun Lee
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Kil Hun Lee has a total of 25 co-authors. Here are the top co-authors by number of shared publications:
- Ryu Kyung Kim
Korea Disease Control and Prevention Agency, Cheongju, Korea
4 shared publications - Chungman Chae
University of California
3 shared publications - Eun Jung Jang
Korea Disease Control and Prevention Agency, Cheongju, Korea
3 shared publications - Ji Hae Hwang
Division of Epidemiological Investigation Analysis, Korea Disease Control and Prevention Agency, Cheongju, Republic of Korea
3 shared publications - Young-Joon Park
Division of Tuberculosis Policy, Korea Disease Control and Prevention Agency, Cheongju, Korea
3 shared publications - Ju Hee Lee
Division of Epidemiological Investigation Analysis, Korea Disease Control and Prevention Agency, Cheongju, Republic of Korea
2 shared publications
Latest Publications
- Open Access
- 10 August 2023
- Published by Elsevier in International Journal of Infectious Diseases
- Vol. 135, 95-100
Comparing the effectiveness of bivalent and monovalent COVID-19 vaccines against COVID-19 infection during the winter season of 2022-2023: A real-world retrospective observational matched cohort study in the Republic of Korea
- 10 August 2023
- Published by Elsevier in International Journal of Infectious Diseases
- Vol. 135, 95-100
Open AccessComparing the effectiveness of bivalent and monovalent COVID-19 vaccines against COVID-19 infection during the winter season of 2022-2023: A real-world retrospective observational matched cohort study in the Republic of Korea
- Open Access
- 30 June 2023
- Published by Korea Disease Control and Prevention Agency in Osong Public Health and Research Perspectives
- Vol. 14 (3) , 164-172
Estimating the number of severe COVID-19 cases and COVID-19-related deaths averted by a nationwide vaccination campaign in Republic of Korea
Objectives: The Korea Disease Control and Prevention Agency promotes vaccination by regularly providing information on its benefits for reducing the severity of coronavirus disease 2019 (COVID-19). This study aimed to analyze the number of averted severe COVID-19 cases and COVID-19-related deaths by age group and quantify the impact of Republic of Korea’s nationwide vaccination campaign.Methods: We analyzed an integrated database from the beginning of the vaccination campaign on February 26, 2021 to October 15, 2022. We estimated the cumulative number of severe cases and COVID-19-related deaths over time by comparing observed and estimated cases among unvaccinated and vaccinated groups using statistical modeling. We compared daily age-adjusted rates of severe cases and deaths in the unvaccinated group to those in the vaccinated group and calculated the susceptible population and proportion of vaccinated people by age.Results: There were 23,793 severe cases and 25,441 deaths related to COVID-19. We estimated that 119,579 (95% confidence interval [CI], 118,901–120,257) severe COVID-19 cases and 137,636 (95% CI, 136,909–138,363) COVID-19-related deaths would have occurred if vaccination had not been performed. Therefore, 95,786 (95% CI, 94,659–96,913) severe cases and 112,195 (95% CI, 110,870–113,520) deaths were prevented as a result of the vaccination campaign.Conclusion: We found that, if the nationwide COVID-19 vaccination campaign had not been implemented, the number of severe cases and deaths would have been at least 4 times higher. These findings suggest that Republic of Korea’s nationwide vaccination campaign reduced the number of severe cases and COVID-19 deaths.
- 30 June 2023
- Published by Korea Disease Control and Prevention Agency in Osong Public Health and Research Perspectives
- Vol. 14 (3) , 164-172
Open AccessEstimating the number of severe COVID-19 cases and COVID-19-related deaths averted by a nationwide vaccination campaign in Republic of Korea
Objectives: The Korea Disease Control and Prevention Agency promotes vaccination by regularly providing information on its benefits for reducing the severity of coronavirus disease 2019 (COVID-19). This study aimed to analyze the number of averted severe COVID-19 cases and COVID-19-related deaths by age group and quantify the impact of Republic of Korea’s nationwide vaccination campaign.Methods: We analyzed an integrated database from the beginning of the vaccination campaign on February 26, 2021 to October 15, 2022. We estimated the cumulative number of severe cases and COVID-19-related deaths over time by comparing observed and estimated cases among unvaccinated and vaccinated groups using statistical modeling. We compared daily age-adjusted rates of severe cases and deaths in the unvaccinated group to those in the vaccinated group and calculated the susceptible population and proportion of vaccinated people by age.Results: There were 23,793 severe cases and 25,441 deaths related to COVID-19. We estimated that 119,579 (95% confidence interval [CI], 118,901–120,257) severe COVID-19 cases and 137,636 (95% CI, 136,909–138,363) COVID-19-related deaths would have occurred if vaccination had not been performed. Therefore, 95,786 (95% CI, 94,659–96,913) severe cases and 112,195 (95% CI, 110,870–113,520) deaths were prevented as a result of the vaccination campaign.Conclusion: We found that, if the nationwide COVID-19 vaccination campaign had not been implemented, the number of severe cases and deaths would have been at least 4 times higher. These findings suggest that Republic of Korea’s nationwide vaccination campaign reduced the number of severe cases and COVID-19 deaths.
- Open Access
- 1 January 2023
- Published by XMLink in Journal of Korean Medical Science
- Vol. 38 (46) , e396
Comparative Effectiveness of COVID-19 Bivalent Versus Monovalent mRNA Vaccines in the Early Stage of Bivalent Vaccination in Korea: October 2022 to January 2023
Kim RK, et al. J Korean Med Sci. 2023 Nov;38:e396. https://doi.org/10.3346/jkms.2023.38.e396
- 1 January 2023
- Published by XMLink in Journal of Korean Medical Science
- Vol. 38 (46) , e396
Open AccessComparative Effectiveness of COVID-19 Bivalent Versus Monovalent mRNA Vaccines in the Early Stage of Bivalent Vaccination in Korea: October 2022 to January 2023
Kim RK, et al. J Korean Med Sci. 2023 Nov;38:e396. https://doi.org/10.3346/jkms.2023.38.e396
- Open Access
- 1 January 2023
- Published by XMLink in Journal of Korean Medical Science
- Vol. 38 (34) , e269
Risk Factors Related to COVID-19 Reinfection and Fatality During the Omicron (BA.1/BA.2) Period in Korea
Lee JH, et al. J Korean Med Sci. 2023 Aug;38(34):e269. https://doi.org/10.3346/jkms.2023.38.e269
- 1 January 2023
- Published by XMLink in Journal of Korean Medical Science
- Vol. 38 (34) , e269
Open AccessRisk Factors Related to COVID-19 Reinfection and Fatality During the Omicron (BA.1/BA.2) Period in Korea
Lee JH, et al. J Korean Med Sci. 2023 Aug;38(34):e269. https://doi.org/10.3346/jkms.2023.38.e269